Clinical Trials on Psoriasis
Total 2181 results
-
University of OxfordRecruitingPsoriatic ArthritisUnited Kingdom
-
University of OxfordNational Institute for Health Research, United KingdomRecruitingPsoriatic ArthritisUnited Kingdom
-
Novartis PharmaceuticalsActive, not recruiting
-
Aclaris Therapeutics, Inc.TerminatedPsoriatic ArthritisUnited States, Poland
-
UCB Biopharma SRLCompletedPsoriatic ArthritisUnited States, Australia, Canada, Czechia, Germany, Hungary, Italy, Japan, Poland, Russian Federation, United Kingdom
-
Bio-Thera SolutionsCompletedPsoriatic ArthritisChina
-
University of PennsylvaniaPfizerActive, not recruitingPsoriasis | Psoriatic ArthritisUnited States
-
The Royal Wolverhampton Hospitals NHS TrustActive, not recruitingPsoriatic ArthritisUnited Kingdom
-
Novartis PharmaceuticalsCompletedPsoriasis | Psoriatic ArthritisSwitzerland
-
UCB Biopharma SRLCompletedPsoriatic ArthritisUnited States, Czechia, Germany, Hungary, Poland, Russian Federation
-
AbbVieCompleted
-
Bio-Thera SolutionsCompletedPsoriatic ArthritisChina
-
Cliniques universitaires Saint-Luc- Université...AmgenCompletedPsoriatic ArthritisBelgium
-
Cliniques universitaires Saint-Luc- Université...University Hospital, Ghent; Janssen-Cilag International NVCompletedPsoriatic ArthritisBelgium
-
AmgenCompletedPsoriatic ArthritisSpain, Belgium, Denmark, United States, Germany, Russian Federation, Austria, United Kingdom, Canada, Italy, Switzerland
-
Gilead SciencesGalapagos NVTerminatedPsoriatic ArthritisKorea, Republic of, United States, Taiwan, Australia, Canada, Japan, Poland, Spain, New Zealand, Czechia, Hungary, Bulgaria, Russian Federation
-
Bristol-Myers SquibbCompletedPsoriatic ArthritisItaly, South Africa, United States, Spain, Germany, Mexico, Israel, France, Greece, Canada, Brazil, Czechia, Peru, Poland, Argentina, Colombia, Chile
-
Gilead SciencesGalapagos NVTerminatedPsoriatic ArthritisKorea, Republic of, United States, Australia, Belgium, Canada, Czechia, Hungary, Japan, Poland, Spain, Taiwan
-
AmgenCompletedPhase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque PsoriasisPsoriasis | Psoriatic ArthritisUnited States, Canada, United Kingdom, Australia, Hungary, Belgium, Netherlands, Germany, Czechia, Estonia, Latvia
-
Dr. Frank BehrensJanssen-Cilag Ltd.Completed
-
Genesis Pharma S.A.Celgene; AmgenActive, not recruitingPsoriatic ArthritisGreece
-
Novartis PharmaceuticalsCompletedPsoriatic ArthritisUnited States, Puerto Rico
-
PfizerCompleted
-
University of PennsylvaniaCompleted
-
Instituto de Medicina Molecular João Lobo AntunesMerck Sharp & Dohme LLCCompleted
-
Janssen Research & Development, LLCCompletedPsoriatic ArthritisUnited States, Germany, Spain, Poland, Romania, Canada, Russian Federation
-
Bausch Health Americas, Inc.CompletedPsoriatic ArthritisUnited States, France, Hungary, Mexico, Poland, Germany, Canada, Greece, Russian Federation, Latvia
-
Eli Lilly and CompanyCompletedPsoriatic ArthritisUnited States, France, Taiwan, Spain, Australia, Germany, United Kingdom, Poland, Czechia, Italy
-
AmgenCompletedPsoriatic ArthritisBelgium, Canada, United Kingdom, Germany, Netherlands
-
Eli Lilly and CompanyCompletedPsoriatic ArthritisSpain, Bulgaria, Czechia, Estonia, Mexico, Poland, Ukraine, United States, South Africa, Russian Federation, Slovakia, United Kingdom
-
AbbVieCompleted
-
Imperial College Healthcare NHS TrustMerck Sharp & Dohme LLC; Imperial College LondonTerminatedPsoriatic ArthritisUnited Kingdom
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Completed
-
Norwegian University of Science and TechnologyHelse Midt-NorgeCompletedPsoriatic Arthritis
-
Novartis PharmaceuticalsCompletedPsoriatic ArthritisGermany, United Kingdom, United States, Belgium, Philippines, Singapore, Thailand, Brazil, Czech Republic, Italy, Argentina, Israel, Russian Federation, Bulgaria, Romania, Australia, Canada, Poland, Slovakia
-
UCB CelltechParexel; Comac Medical; MAC Clinical Research; ARENSIA, MoldovaCompletedPsoriatic ArthritisBulgaria, Moldova, Republic of, United Kingdom
-
AbbVie (prior sponsor, Abbott)CompletedPsoriatic ArthritisGermany
-
Dr. FRANCISCO J. BLANCO-GARCIACompletedA 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic ArthritisPsoriatic ArthritisSpain
-
Reumatologia Integral LTDAUnknownPsoriatic ArthritisColombia
-
Bristol-Myers SquibbTerminatedPsoriatic ArthritisArgentina, France, Italy, United States, Canada, Belgium, Netherlands, Australia, Germany, South Africa, Spain, Norway
-
AmgenImmunex CorporationCompletedPsoriasis | Psoriatic Arthritis
-
National Taiwan University HospitalCompleted
-
Hansoh BioMedical R&D CompanyNot yet recruiting
-
Brigham and Women's HospitalJanssen Scientific Affairs, LLCNot yet recruitingArthritis | Psoriatic Arthritis
-
University of OxfordUniversity College DublinRecruiting
-
Global Healthy Living FoundationThe Cleveland ClinicRecruiting
-
Diakonhjemmet HospitalRecruiting
-
University of OxfordAmgenRecruitingPsoriatic ArthritisSpain, France, United Kingdom, Germany, Italy